Experienced in Chromosome 7p Deletion

Jun Saegusa

Kobe, JP 
Experienced in Chromosome 7p Deletion
Kobe, JP 
OverviewLocationsClinical Research

Overview

Jun Saegusa practices in Kobe, Japan. Mr. Saegusa is rated as an Experienced expert by MediFind in the treatment of Chromosome 7p Deletion. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Castleman Disease, and Hydrocephalus Skeletal Anomalies.

His clinical research consists of co-authoring 113 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chromosome 7p Deletion.

Gender
Male

Locations

Kobe, Japan
Other Locations
Fukushima, 9750036, Japan
Shiga Prefectural Fisheries Experimental Station, 2138-3, Hikone, 5220057, Japan
Tokai, 3191195, Japan
Chiyoda, 1008577, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3

113 Total Publications

Optimization of Preemptive Therapy for Cytomegalovirus Infections With Valganciclovir Based on Therapeutic Drug Monitoring: Protocol for a Phase II, Single-Center, Single-Arm Trial.
Optimization of Preemptive Therapy for Cytomegalovirus Infections With Valganciclovir Based on Therapeutic Drug Monitoring: Protocol for a Phase II, Single-Center, Single-Arm Trial.
Journal: JMIR research protocols
Published: February 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Saegusa's expertise for a condition
ConditionClose
      View All 50 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile